The law firm Wisner Baum, along with co-counsel, has rested its case in the lawsuit Russell v. Boehringer Ingelheim Pharmaceuticals, Inc. The trial, which focuses on allegations related to Zantac and its potential cancer risks, is expected to proceed until mid to late November. This case represents one of many efforts to hold pharmaceutical companies accountable for their role in the Zantac litigation.

By submitting your cell phone number, you agree to receive marketing messages from tortadvisor.com and its partners via voice calls, AI-generated calls, text messaging, or other automated methods. For details on how we use your information, please refer to our Privacy Policy.

Partners Off-Canvas (Hidden)